Previous Article | Next Article 
Molecular and Cellular Biology, February 2004, p. 1401-1410, Vol. 24, No. 3
0270-7306/04/$08.00+0 DOI: 10.1128/MCB.24.3.1401-1410.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
c-Kit-Mediated Overlapping and Unique Functional and Biochemical Outcomes via Diverse Signaling Pathways
Li Hong, Veerendra Munugalavadla, and Reuben Kapur*
Department of Pediatrics, Herman B. Wells Center for Pediatric Research, and Department of Molecular Biology and Biochemistry, Indiana University School of Medicine, Indianapolis, Indiana 46202
Received 7 July 2003/
Returned for modification 18 August 2003/
Accepted 3 November 2003
A critical issue in understanding receptor tyrosine kinase signaling is the individual contribution of diverse signaling pathways in regulating cellular growth, survival, and migration. We generated a functionally and biochemically inert c-Kit receptor that lacked the binding sites for seven early signaling pathways. Restoring the Src family kinase (SFK) binding sites in the mutated c-Kit receptor restored cellular survival and migration but only partially rescued proliferation and was associated with the rescue of the Ras/mitogen-activated protein kinase, Rac/JNK kinase, and phosphatidylinositol 3-kinase (PI-3 kinase)/Akt pathways. In contrast, restoring the PI-3 kinase binding site in the mutated receptor did not affect cellular proliferation but resulted in a modest correction in cell survival and migration, despite a complete rescue in the activation of the PI-3 kinase/Akt pathway. Surprisingly, restoring the binding sites for Grb2, Grb7, or phospholipase C-
had no effect on cellular growth or survival, migration, or activation of any of the downstream signaling pathways. These results argue that SFKs play a unique role in the control of multiple cellular functions and in the activation of distinct biochemical pathways via c-Kit.
* Corresponding author. Mailing address: Herman B. Wells Center for Pediatric Research, Cancer Research Building, 1044 W. Walnut St., Room 425, Indianapolis, IN 46202. Phone: (317) 278-0543. Fax: (317) 274-8679. E-mail: rkapur{at}iupui.edu.
Molecular and Cellular Biology, February 2004, p. 1401-1410, Vol. 24, No. 3
0022-538X/04/$08.00+0 DOI: 10.1128/MCB.24.3.1401-1410.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.
This article has been cited by other articles:
-
Schilder, R. J., Sill, M. W., Lee, R. B., Shaw, T. J., Senterman, M. K., Klein-Szanto, A. J., Miner, Z., Vanderhyden, B. C.
(2008). Phase II Evaluation of Imatinib Mesylate in the Treatment of Recurrent or Persistent Epithelial Ovarian or Primary Peritoneal Carcinoma: A Gynecologic Oncology Group Study. JCO
26: 3418-3425
[Abstract]
[Full Text]
-
Eisele, Y. S., Baumann, M., Klebl, B., Nordhammer, C., Jucker, M., Kilger, E.
(2007). Gleevec Increases Levels of the Amyloid Precursor Protein Intracellular Domain and of the Amyloid-beta degrading Enzyme Neprilysin. Mol. Biol. Cell
18: 3591-3600
[Abstract]
[Full Text]
-
Munugalavadla, V., Sims, E. C., Borneo, J., Chan, R. J., Kapur, R.
(2007). Genetic and pharmacologic evidence implicating the p85{alpha}, but not p85{beta}, regulatory subunit of PI3K and Rac2 GTPase in regulating oncogenic KIT-induced transformation in acute myeloid leukemia and systemic mastocytosis. Blood
110: 1612-1620
[Abstract]
[Full Text]
-
Takeshita, S., Faccio, R., Chappel, J., Zheng, L., Feng, X., Weber, J. D., Teitelbaum, S. L., Ross, F. P.
(2007). c-Fms Tyrosine 559 Is a Major Mediator of M-CSF-induced Proliferation of Primary Macrophages. J. Biol. Chem.
282: 18980-18990
[Abstract]
[Full Text]
-
Samayawardhena, L. A., Kapur, R., Craig, A. W. B.
(2007). Involvement of Fyn kinase in Kit and integrin-mediated Rac activation, cytoskeletal reorganization, and chemotaxis of mast cells. Blood
109: 3679-3686
[Abstract]
[Full Text]
-
Yu, M., Luo, J., Yang, W., Wang, Y., Mizuki, M., Kanakura, Y., Besmer, P., Neel, B. G., Gu, H.
(2006). The Scaffolding Adapter Gab2, via Shp-2, Regulates Kit-evoked Mast Cell Proliferation by Activating the Rac/JNK Pathway. J. Biol. Chem.
281: 28615-28626
[Abstract]
[Full Text]
-
Heiss, E., Masson, K., Sundberg, C., Pedersen, M., Sun, J., Bengtsson, S., Ronnstrand, L.
(2006). Identification of Y589 and Y599 in the juxtamembrane domain of Flt3 as ligand-induced autophosphorylation sites involved in binding of Src family kinases and the protein tyrosine phosphatase SHP2. Blood
108: 1542-1550
[Abstract]
[Full Text]
-
Wei, X., Ni, S., Correll, P. H.
(2005). Uncoupling Ligand-dependent and -independent Mechanisms for Mitogen-activated Protein Kinase Activation by the Murine Ron Receptor Tyrosine Kinase. J. Biol. Chem.
280: 35098-35107
[Abstract]
[Full Text]
-
Munugalavadla, V., Dore, L. C., Tan, B. L., Hong, L., Vishnu, M., Weiss, M. J., Kapur, R.
(2005). Repression of c-Kit and Its Downstream Substrates by GATA-1 Inhibits Cell Proliferation during Erythroid Maturation. Mol. Cell. Biol.
25: 6747-6759
[Abstract]
[Full Text]
-
Couldrey, C., Bradley, H. L., Bunting, K. D.
(2005). A STAT5 modifier locus on murine chromosome 7 modulates engraftment of hematopoietic stem cells during steady-state hematopoiesis. Blood
105: 1476-1483
[Abstract]
[Full Text]
-
Lennartsson, J., Jelacic, T., Linnekin, D., Shivakrupa, R.
(2005). Normal and Oncogenic Forms of the Receptor Tyrosine Kinase Kit. Stem Cells
23: 16-43
[Abstract]
[Full Text]
-
Kimura, Y., Jones, N., Kluppel, M., Hirashima, M., Tachibana, K., Cohn, J. B., Wrana, J. L., Pawson, T., Bernstein, A.
(2004). Targeted mutations of the juxtamembrane tyrosines in the Kit receptor tyrosine kinase selectively affect multiple cell lineages. Proc. Natl. Acad. Sci. USA
101: 6015-6020
[Abstract]
[Full Text]
Copyright © 2004 by the American Society for Microbiology. All rights reserved.